News

Open-source PBPK model update for new DDIs

Check out this new release of the OSP CYP3A4-DDI qualification report, where Pharmetheus in partnership with Boehringer Ingelheim contributed by adding a perpetrator contributed by adding a perpetrator (fluconazole) with 3 victims

Read More »

Corporate Social Responsibility

For Pharmetheus, our corporate social responsibility (CSR) ambitions are to become an even more sustainable and responsible company. Like all initiatives within Pharmetheus, our CSR strategy stems from our vision and core

Read More »

New research projects in PBPK

Our engagement in PBPK-QSP takes many forms! We’ve recently kicked off three new research projects, about i) an infrastructure for streamlining processes of PBPK projects, ii) a framework for evaluating the performance

Read More »

Looking to hire a project coordinator

Do you have experience working as Project Coordinator? Do you want to be part of a fantastic team in an expanding international organization? Pharmetheus keeps moving forward and is looking to grow

Read More »

Excited about WCoP 2022

Pharmetheus is a proud sponsor, workshop organizer, poster author, and attendee delegation to WCoP in March. Hats off to the hosts for fantastic organization as illustrated in this video.

Read More »

PBPK Webinar replay available

Pharmetheus’ webinar regarding A Growing Network of Open Science: PBPK modelling of Drug–Drug Interactions with the Open Systems Pharmacology Suite, was well attended and received two weeks ago. If you missed it,

Read More »

Welcome Patrik Ejerhed!

We are very happy to welcome Patrik Ejerhed as a Financial Controller. Patrik’s experience includes financial auditing at PricewaterhouseCoopers and KPMG. He will be based in Uppsala. See Patrik’s bio here.

Read More »